Jim Jackson has a diverse work experience in the pharmaceutical and biotech industry. Jim has held various leadership roles in companies such as Precigen, Kite Pharma, MD Anderson Cancer Center, Regeneron Pharmaceuticals, GSK, Novartis Vaccines, Merck, Pfizer, and Dow AgroSciences. Jim's roles have included executive positions in manufacturing operations, cell therapy manufacturing, process development, and global contract manufacturing. Jim has also worked in supply chain coordination and scientific research.
Jim Jackson attended Ball State University, where they pursued a Bachelor of Science degree in Biology/Microbiology. Additionally, they studied at Michigan State University's Eli Broad College of Business, where they obtained a Master of Business Administration (MBA) with a focus on Integrative Management. The specific start and end years for both their undergraduate and graduate studies are not provided.
August, 2022 - present